The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality. This annual prize, made possible by the generosity of the Charles and Margery Barancik Foundation, has been increased to $125,000 to be used at the discretion of the recipient. New this year, the prize also includes a $200,000 fellowship award at the recipient’s institution for a trainee chosen by the recipient.
The goal of the prize is to recognize innovation in scientific research in the field of multiple sclerosis. Nominations must be submitted on behalf an individual, or a team, by one or more colleagues or mentors. Self-nominations are not permitted.
Nomination letters should address the nominee’s scientific accomplishments with an emphasis on the innovative and impactful aspects of the nominee’s work, including a maximum of 2 journal citations if appropriate. Include the current institution and contact information for the nominator and nominee. Please ensure the eligibility criteria below are met prior to submitting nominations.
Previous nominations are not automatically carried forward. If you wish to re-nominate a previous candidate, please update the earlier nomination with any significant developments and/or citations and resubmit.
Deadline for Nominations: Aug. 11, 2025
Any investigator(s) active in MS research is eligible for the prize, and the nominee(s) may be from any institution or organization— public or private, government, as well as commercial entities. The award is intended for early to mid-career MS researchers. Nominees should have no more than 20 years of experience as an independent investigator or team leader to be eligible. There are no specific requirements for residency or citizenship. Nominees need not be current or past grantees of the National MS Society.